HFA Premium Access

Age dependency of cardiovascular outcomes with the amyloidogenic p142I transthyretin variant among black individuals

Congress Presentation

About the speaker

Doctor Senthil Selvaraj

Duke University School of Medicine, Durham (United States of America)
2 presentations
0 follower

4 more presentations in this session

Demographic characteristics and clinical follow-up of the 2788 transthyretin amyloid cardiomyopathy patients treated with tafamidis during the French Early Access Program (RTU)

Speaker: Professor J. Inamo (Fort de France, MQ)

Thumbnail

Prevalence and characteristics of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: final analysis of the TTRACK study

Speaker: Professor N. Piriou (Nantes, FR)

Thumbnail

Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping

Speaker: Doctor A. Ioannou (Greater London, GB)

Thumbnail

Effect of patisiran treatment in patients with hATTR amyloidosis with cardiomyopathy and polyneuropathy: post-hoc analysis of the APOLLO-B study

Speaker: Professor F. Gustafsson (Copenhagen, DK)

Thumbnail

Access the full session

Cardiac amyloidosis from epidemiology to treatment

Speakers: Doctor S. Selvaraj, Professor J. Inamo, Professor N. Piriou, Doctor A. Ioannou, Professor F. Gustafsson
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations